BioSpace News Archive

Vor Bio, a clinical-stage cell and genome engineering company, announced that Dr. Christopher Slapak, Chief Medical Officer for Vor Bio plans to retire.

Biohaven Pharmaceutical Holding Company Ltd. announced the publication of new real-world research showing that as migraine-related disability increases, healthcare utilization also increases among Americans with episodic migraine.

Light Bio, Inc. and Ginkgo Bioworks announced a collaboration to leverage Ginkgo’s plant cell assays for bioluminescence engineering.

Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2022 first quarter results after market close on Thursday, May 12, 2022.

Aditxt, Inc., a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, is announcing a multiyear partnership with GRS, an affiliate of marketing powerhouse Guthy-Renker, LLC.

Akron BioProducts, a leading supplier of cGMP-compliant materials and technologies for cell and gene therapy manufacturing, today announced the launch of its Closed System Solutions™ (CSS) product line, aimed at functionally closing critical unit operations in cell and gene therapy manufacturing workflows.

According to Report Study, the global AI in Drug Discovery Market was valued USD 1.0 billion in 2021 and is set to reach USD 10.80 billion by 2030 and growing at a CAGR of 36% from 2022 to 2030.

The global Biologics Contract Manufacturing Market was valued at USD 17.45 billion in 2021 and it is expected to reach USD 30.9 billion by 2030 with a CAGR of 8.4% during the prediction period 2022 to 2030.

The global cell & tissue preservation market revenue was valued USD 4.6 billion in 2021 and it is expected to grow USD 10.1 billion by 2030 with a CAGR of 11.7% from 2022 to 2030.

According to Report, the global platelet rich plasma market was worth around at USD 300 Million in 2021 and it is expected to reach USD 890.9 Million by 2030 with a CAGR of 11.0% from 2022 to 2030.